Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | LPTX |
---|---|---|
09:32 ET | 321 | 1.14 |
09:34 ET | 25350 | 1.1425 |
09:38 ET | 7700 | 1.13 |
09:41 ET | 3205 | 1.13 |
09:43 ET | 3982 | 1.13 |
09:48 ET | 300 | 1.15 |
09:52 ET | 11165 | 1.15 |
09:54 ET | 1000 | 1.17 |
09:59 ET | 1350 | 1.16 |
10:10 ET | 2895 | 1.17 |
10:12 ET | 709 | 1.17 |
10:14 ET | 100 | 1.17 |
10:17 ET | 100 | 1.155 |
10:24 ET | 364 | 1.17 |
10:26 ET | 6419 | 1.185 |
10:30 ET | 4130 | 1.17 |
10:32 ET | 200 | 1.17 |
10:33 ET | 1300 | 1.17 |
10:35 ET | 1000 | 1.17 |
10:39 ET | 1833 | 1.155 |
10:42 ET | 402 | 1.16 |
10:44 ET | 2382 | 1.17 |
10:50 ET | 399 | 1.18 |
10:53 ET | 1701 | 1.17 |
10:55 ET | 4139 | 1.16 |
11:00 ET | 1998 | 1.17 |
11:06 ET | 3200 | 1.17 |
11:08 ET | 600 | 1.17 |
11:09 ET | 1200 | 1.17 |
11:11 ET | 2390 | 1.18 |
11:13 ET | 230 | 1.18 |
11:18 ET | 233 | 1.19 |
11:22 ET | 100 | 1.19 |
11:24 ET | 100 | 1.18 |
11:26 ET | 588 | 1.18 |
11:29 ET | 100 | 1.17 |
11:31 ET | 158 | 1.175 |
11:33 ET | 4900 | 1.17 |
11:36 ET | 300 | 1.16 |
11:42 ET | 2975 | 1.1601 |
11:47 ET | 100 | 1.1653 |
12:02 ET | 100 | 1.1686 |
12:05 ET | 200 | 1.165 |
12:07 ET | 600 | 1.16 |
12:18 ET | 5733 | 1.16 |
12:23 ET | 200 | 1.165 |
12:27 ET | 5800 | 1.16 |
12:32 ET | 100 | 1.1686 |
12:34 ET | 100 | 1.165 |
12:38 ET | 100 | 1.16 |
12:39 ET | 100 | 1.16 |
12:41 ET | 200 | 1.16 |
12:43 ET | 100 | 1.16 |
12:45 ET | 200 | 1.16 |
12:48 ET | 400 | 1.16 |
12:50 ET | 600 | 1.16 |
12:52 ET | 200 | 1.17 |
12:54 ET | 200 | 1.16 |
12:56 ET | 100 | 1.16 |
12:57 ET | 300 | 1.16 |
01:12 ET | 300 | 1.16 |
01:15 ET | 300 | 1.169 |
01:24 ET | 550 | 1.16 |
01:28 ET | 100 | 1.165 |
01:30 ET | 100 | 1.16 |
01:32 ET | 200 | 1.165 |
01:33 ET | 700 | 1.165 |
01:39 ET | 3840 | 1.17 |
01:53 ET | 1422 | 1.18 |
01:55 ET | 4083 | 1.185 |
01:57 ET | 778 | 1.18 |
02:00 ET | 100 | 1.179 |
02:02 ET | 110 | 1.175 |
02:06 ET | 2212 | 1.17 |
02:08 ET | 410 | 1.17 |
02:15 ET | 1200 | 1.17 |
02:29 ET | 6200 | 1.17 |
02:31 ET | 100 | 1.17 |
02:33 ET | 2142 | 1.175 |
02:36 ET | 19798 | 1.18 |
02:45 ET | 845 | 1.18 |
02:47 ET | 2162 | 1.175 |
02:51 ET | 5100 | 1.175 |
03:00 ET | 8137 | 1.16 |
03:02 ET | 200 | 1.16 |
03:03 ET | 100 | 1.16 |
03:07 ET | 100 | 1.16 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Leap Therapeutics Inc | 101.6M | -2.1x | --- |
Summit Therapeutics Inc | 98.1M | -1.0x | --- |
Checkpoint Therapeutics Inc | 100.8M | -1.3x | --- |
Enochian Biosciences Inc | 102.2M | -2.4x | --- |
Brainstorm Cell Therapeutics Inc | 100.7M | -4.3x | --- |
Achilles Therapeutics PLC | 102.7M | -1.5x | --- |
Leap Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on developing therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways and by harnessing the immune system to attack cancer cells. The Company’s clinical stage program is DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1 (DKK1). DKK1 is a protein that regulates the Wnt signaling pathways and enables tumor cells to proliferate and spread, as well as suppresses the immune system from attacking the tumor. When DKN-01 binds to DKK1, an anti-tumor effect can be generated. DKK1 is a cell secreted protein that research has found its role in embryonic development. DKN-01 is an affinity, neutralizing monoclonal antibody targeting DKK1. DKN-01 reduces free DKK1 levels and has demonstrated an anti-tumor effect in preclinical models.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $101.6M |
---|---|
Revenue (TTM) | $1.1M |
Shares Outstanding | 88.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.66 |
EPS | $-0.55 |
Book Value | $1.22 |
P/E Ratio | -2.1x |
Price/Sales (TTM) | 90.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -3,812.09% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.